Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28172871 | 0.89 | ALDH1A1 (0.39) | ALDH1A1MAPK1KMT2AMAOB | |
| SCHEMBL16675618 | 0.84 | ALDH1A1 (0.40) | ALDH1A1MAPK1KMT2A | |
| SCHEMBL1054915 | 0.84 | ALDH1A1 (0.37) | ALDH1A1MAPK1KMT2AMAOB | |
| SCHEMBL2616010 | 0.83 | ALDH1A1 (0.36) | ALDH1A1MAPK1KMT2A | |
| SCHEMBL28849663 | 0.81 | ALDH1A1 (0.37) | ALDH1A1MAPK1KMT2AMAOB | |
| SCHEMBL11113228 | 0.79 | MAOB (0.36) | ALDH1A1MAPK1KMT2AMAOB | |
| SCHEMBL12035983 | 0.78 | FFAR4 (0.39) | KMT2A | |
| SCHEMBL17531792 | 0.76 | KMT2A (0.38) | ALDH1A1MAPK1KMT2AMAOB | |
| SCHEMBL9518641 | 0.76 | ALDH1A1 (0.36) | ALDH1A1MAPK1KMT2AMAOB | |
| SCHEMBL28172137 | 0.76 | ALDH1A1 (0.36) | ALDH1A1MAPK1KMT2AMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2966108-B1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | SAUDI ARAMCO TECH CO (SA) | 2021-03-31 | — | — | EP | disclosed |
| US-10662211-B2 | Catalysts and methods for polymer synthesis | Saurdi Aramco Technologies Company (SA) | 2020-05-26 | — | — | US | disclosed |
| US-20180179242-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. | 2018-06-28 | — | — | US | disclosed |
| US-20180179242-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. | 2018-06-28 | — | — | US | disclosed |
| US-9951096-B2 | Catalysts and methods for polymer synthesis | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2018-04-24 | — | — | US | disclosed |
| US-9951096-B2 | Catalysts and methods for polymer synthesis | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2018-04-24 | — | — | US | disclosed |
| US-9718901-B2 | Resin composition and pattern forming method using the same | FUJIFILM CORPORATION (JP) | 2017-08-01 | — | — | US | disclosed |
| US-9718901-B2 | Resin composition and pattern forming method using the same | FUJIFILM CORPORATION (JP) | 2017-08-01 | — | — | US | disclosed |
| US-20170183369-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2017-06-29 | — | — | US | disclosed |
| US-20170183369-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2017-06-29 | — | — | US | disclosed |
| US-8378134-B2 | Hydroxylated contrast enhancement agents | GENERAL ELECTRIC COMPANY (US) | 2013-02-19 | — | — | US | disclosed |
| US-20110152497-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-20110152497-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| WO-2011039244-A1 | HYDROXYLATED CONTRAST ENHANCEMENT AGENTS AND INTERMEDIATES THEREOF | GENERAL ELECTRIC COMPANY (US) | 2011-04-07 | — | — | WO | disclosed |
| US-20110076237-A1 | Hydroxylated Contrast Enhancement Agents | GENERAL ELECTRIC COMPANY (US) | 2011-03-31 | — | — | US | disclosed |
| US-20110076237-A1 | Hydroxylated Contrast Enhancement Agents | GENERAL ELECTRIC COMPANY (US) | 2011-03-31 | — | — | US | disclosed |
| US-20110077417-A1 | Intermediates for Hydroxylated Contrast Enhancement Agents | GENERAL ELECTRIC COMPANY (US) | 2011-03-31 | — | — | US | disclosed |
| US-20110077417-A1 | Intermediates for Hydroxylated Contrast Enhancement Agents | GENERAL ELECTRIC COMPANY (US) | 2011-03-31 | — | — | US | disclosed |
| US-20110077396-A1 | INTERMEDIATES FOR HYDROXYLATED CONTRAST ENHANCEMENT AGENTS | GENERAL ELECTRIC COMPANY (US) | 2011-03-31 | — | — | US | disclosed |
| WO-2010022388-A2 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. (US) | 2010-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662211-B2 | Catalysts and methods for polymer synthesis | PPOX, COASY, SOD1 | ALDH1A1 2255/4885MAPK1 4309/4885KMT2A 1825/4885 |
| US-20110077417-A1 | Intermediates for Hydroxylated Contrast Enhancement Agents | RXFP3, HCAR3, RXFP1 | ALDH1A1 3419/4885MAPK1 2490/4885KMT2A 4210/4885 |
| US-20110077396-A1 | INTERMEDIATES FOR HYDROXYLATED CONTRAST ENHANCEMENT AGENTS | C1R, HCAR3, C3AR1 | ALDH1A1 4130/4885MAPK1 2722/4885KMT2A 4347/4885 |
| US-20180179242-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | ALDH1A1 2255/4885MAPK1 4309/4885KMT2A 1825/4885 |
| US-20110076237-A1 | Hydroxylated Contrast Enhancement Agents | C5, C1R, HAMP | ALDH1A1 3854/4885MAPK1 3585/4885KMT2A 4097/4885 |
| US-20170183369-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | ALDH1A1 2255/4885MAPK1 4309/4885KMT2A 1825/4885 |
| US-20110152497-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | ALDH1A1 2255/4885MAPK1 4309/4885KMT2A 1825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.